On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment

Chemotherapy
Grazia R TundoStefano Marini

Abstract

Immune checkpoints are critical regulatory pathways of the immune system which finely tune the response to biological threats. Among them, the CD-28/CTLA-4 and PD-1/PD-L1 axes play a key role in tumour immune escape and are well-established targets of cancer immunotherapy. The clinical experience accumulated to date provides unequivocal evidence that anti-CTLA-4, PD-1, or PD-L1 monoclonal antibodies, used as monotherapy or in combination regimes, are effective in a variety of advanced/metastatic types of cancer, with improved clinical outcomes compared to conventional chemotherapy. However, the therapeutic success is currently restricted to a limited subset of patients and reliable predictive biomarkers are still lacking. Key Message: The identification and characterization of additional co-inhibitory pathways as novel pharmacological targets to improve the clinical response in refractory patients has led to the development of different immune checkpoint inhibitors, the activities of which are currently under investigation. In this review, we discuss recent literature data concerning the mechanisms of action of next-generation monoclonal antibodies targeting LAG-3, TIM-3, and TIGIT co-inhibitory molecules that are being explore...Continue Reading

References

Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jul 10, 1998·Immunology Letters·B HuardF Triebel
Oct 12, 2000·Nature Cell Biology·G BergersD Hanahan
Sep 5, 2002·European Journal of Immunology·Creg J WorkmanDario A A Vignali
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Apr 3, 2003·European Journal of Immunology·Creg J Workman, Dario A A Vignali
Oct 28, 2003·Nature Immunology·Francesca FallarinoPaolo Puccetti
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
May 12, 2005·Immunology·Laëtitia Maçon-Lemaître, Frédéric Triebel
Jun 23, 2005·European Journal of Immunology·Malgorzata KisielowKlaus Karjalainen
Jul 9, 2005·Trends in Molecular Medicine·Jennifer Hartt MeyersVijay K Kuchroo
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Dec 13, 2005·Molecular Immunology·Johannes Martinus DijkstraUwe Fischer
Oct 31, 2006·Biochemical and Biophysical Research Communications·Philipp S van de WeyerE Wolfgang Kuehn
Nov 11, 2006·The Journal of Investigative Dermatology·Zoltan WienerAndras Falus
Jul 11, 2007·Blood·Susumu NakaeStephen J Galli
Sep 28, 2007·Nature·Ralph M Steinman, Jacques Banchereau
Oct 13, 2007·The Journal of Clinical Investigation·Joseph F GrossoCharles G Drake
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bitao LiangRaphael Clynes
Nov 15, 2008·The Oncologist·Jedd D Wolchok, Yvonne Saenger
Dec 27, 2008·Journal of Molecular Biology·Magda GioiaMassimo Coletta
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Feb 20, 2009·Blood·Masafumi NakayamaKo Okumura
Sep 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chrystelle BrignoneFrédéric Triebel
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Noa StanietskyOfer Mandelboim
Jan 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rosemarie H DeKruyffJosé M Casasnovas
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Junko MatsuzakiKunle Odunsi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 2, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ying LiuChunhong Ma
Sep 8, 2010·The Journal of Experimental Medicine·Kaori SakuishiAna C Anderson
Nov 19, 2010·Current Topics in Microbiology and Immunology·Monica V Goldberg, Charles G Drake
Nov 30, 2010·Cell Stem Cell·Yoshikane KikushigeKoichi Akashi

❮ Previous
Next ❯

Citations

May 14, 2020·Expert Opinion on Investigational Drugs·Laura Amanda BoosJames Larkin
Jul 9, 2020·Scandinavian Journal of Immunology·Anna K Winge-MainElse Marit Inderberg
Feb 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Martina GoracciSerena Marchiò
Feb 23, 2020·Annals of Neurology·Divyanshu DubeyAmanda C Guidon
Jul 8, 2020·International Journal of Molecular Sciences·Daniëlle KrijgsmanPeter J K Kuppen
Apr 3, 2020·International Journal of Molecular Sciences·Vera PetrovaViktor Umansky
May 24, 2020·Antibodies·Josée Golay, Alain E Andrea
Nov 11, 2020·International Journal of Molecular Sciences·Negar HosseinkhaniBehzad Baradaran
Aug 21, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sebastian KleinDoris Helbig
Apr 4, 2021·International Journal of Molecular Sciences·Alexander C ChaconPeter A Prieto
May 1, 2021·Cancers·Dimitri KasakovskiLaura Susok
May 4, 2021·Frontiers in Immunology·Zheying ZhangJiateng Zhong
Jul 24, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Christine E BooneNicole F Steinmetz
Aug 10, 2021·Frontiers in Molecular Biosciences·Fan YangFeng Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.